Novartis Investigative Site
Candiolo 10060
0 studies enrolling now · 2 studies all time
What they study most
Cancer, Neoplasms, Breast
Studies at this site
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
— Completed
BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)
— Completed